2025 International Fall Summit
October 15, 2025 | 12:00 PM EST
- Home
- Clinical Resources Search
- PQI: Advances in MRD Monitoring for Diffuse Large B-Cell Lymphoma (DLBCL)
Advances in MRD Monitoring for Diffuse Large B-Cell Lymphoma (DLBCL)
About this PQI
The purpose of this PQI is to assess an unmet need in the DLBCL patient population by enhancing the ability to evaluate treatment efficacy, monitor disease kinetics and remission, and detect early relapse.

How to Use a Positive Quality Intervention (PQI)
Essentially, it’s a tool to improve patient care by sharing best practices in oncology care. Consider this standardized, peer-review clinical guidance to oncology healthcare teams, enabling you and your team to consistently deliver high-quality care to your patients.
Find a PQIFind Similar Resources
All Resources
PQI
PQI
PQI
PQI
PQI: Bone Health and the Cancer Patient
Author: Nina DiPierro Pharm.D. BCOP, Florida Cancer Specialists and Research Institute | Farishta Manzoor, PharmD, Hartford HealthCare Cancer Institute
Last Updated: 08/03/2025
PQI: Encorafenib (Braftovi®) + Cetuximab (Erbitux®) + mFOLFOX6 for BRAF V600E-Positive Metastatic Colorectal Cancer
Author: Jennah Bauernfeind, PharmD, BCOP
Last Updated: 08/03/2025
PQI: Zolbetuximab (Vyloy®) for Gastroesophageal Cancers
Author: Dr. Reetu Mukherji, MD
Last Updated: 08/03/2025
PQI: Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Author: Syed Zia Khan, PharmD, BCSCP
Last Updated: 08/03/2025
PQI in Action
PQI in Action
PQI in Action
PQI in Action
PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2
Author: Johns Hopkins, MD | The University of Texas MD Anderson Cancer Center, TX
Last Updated: 08/03/2025
PQI in Action: Proactive Symptom Management in Myelofibrosis
Author: Cancer Specialists of North Florida
Last Updated: 08/03/2025
PQI in Action: Sonidegib (Odomzo®) Patient Management
Author: UCLA Medical Center | The Ohio State University Cancer Comprehensive Cancer Center (The James) | WVU Medicine
Last Updated: 08/03/2025
PQI in Action: Larotrectinib (Vitrakvi®) Overview
Author: Upstate Cancer Center/Upstate Golisano Children’s Hospital, NY | Wolfson Children’s Hospital, FL
Last Updated: 08/03/2025
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit
Treatment Support Kit: Mirdametinib
Last Updated: 08/03/2025
Treatment Support Kit: Abemaciclib
Last Updated: 08/03/2025
Treatment Support Kit: Temozolomide
Last Updated: 08/03/2025
Treatment Support Kit: Tivozanib
Last Updated: 08/03/2025
PQI
PQI
PQI
PQI
PQI: Epcoritamab (Epkinly®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma and Follicular Lymphoma
Author: Syed Zia Khan, PharmD, BCSCP
Last Updated: 08/03/2025
PQI: Tafasitamab-cxix (Monjuvi®) for Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Author: Jeff Engle, PharmD, MS
Last Updated: 08/03/2025
PQI: Selinexor (Xpovio®) Patient Management
Author: Jeremiah Moore, PharmD
Last Updated: 08/03/2025
PQI: Loncastuximab tesirine-lpyl (Zynlonta®) in Relapsed/Refractory Large B-Cell Lymphoma
Author: Kelly Valla, PharmD, BCOP
Last Updated: 08/03/2025
PQI
PQI
PQI in Action
PQI: clonoSEQ® Next Generation Sequencing for Minimum Residual Disease Testing in Chronic Lymphocytic Leukemia
Author: Eileen Peng, PharmD, MS
Last Updated: 08/03/2025
PQI: clonoSEQ® Next Generation Sequencing for Minimal Residual Disease Testing in Multiple Myeloma
Author: Kashif Ali, MD
Last Updated: 08/03/2025
PQI in Action: ClonoSEQ® Next Generation Sequencing for Minimal Residual Disease Testing in Multiple Myeloma
Author: Florida Cancer Specialists & Research Institute, FL | Rocky Mountain Cancer Centers, CO
Last Updated: 08/03/2025
PQI in Action
PQI
PQI in Action
PQI in Action
PQI in Action: Management of Tucatinib (Tukysa®) and Trastuzumab in HER2-Positive Metastatic Colorectal Cancer – 2
Author: Johns Hopkins, MD | The University of Texas MD Anderson Cancer Center, TX
Last Updated: 08/03/2025
PQI: Bone Health and the Cancer Patient
Author: Nina DiPierro Pharm.D. BCOP, Florida Cancer Specialists and Research Institute | Farishta Manzoor, PharmD, Hartford HealthCare Cancer Institute
Last Updated: 08/03/2025
PQI in Action: Proactive Symptom Management in Myelofibrosis
Author: Cancer Specialists of North Florida
Last Updated: 08/03/2025
PQI in Action: Sonidegib (Odomzo®) Patient Management
Author: UCLA Medical Center | The Ohio State University Cancer Comprehensive Cancer Center (The James) | WVU Medicine
Last Updated: 08/03/2025